Since my last coverage of Hims & Hers Health (NYSE: HIMS ), its stock has surged by about 24%. After the announcement of the company's Q2'25 earnings report , its pre-market stock price droppedI am an experienced Risk Management Business Analyst at a Systemic Greek Bank, with a strong background in finance and risk analysis. I hold an MSc in Applied Risk Management from the University of Athens and have completed the ACA Certificate Level. My expertise lies in financial analysis, risk management, data analy ...